Quarterly report pursuant to Section 13 or 15(d)

FAIR VALUE MEASUREMENTS. (Tables)

v3.20.1
FAIR VALUE MEASUREMENTS. (Tables)
 3 Months Ended
Mar. 31, 2020
Fair Value Disclosures [Abstract]  
Schedule of used and related fair value for the warrants

Original Issuance   Exercise Price     Volatility     Risk Free Interest Rate     Term (years)     Warrants Outstanding     Fair Value  
12/22/19   $ 1.00       106.0 %     0.21 %     2.75       5,500,000     $ 304,000  

 

Original Issuance   Exercise Price     Volatility     Risk Free Interest Rate     Term (years)     Warrants Outstanding     Fair Value  
12/22/19   $ 1.00       76.0 %     1.66 %     3.00       5,500,000     $ 977,000  

 
Schedule of recurring and nonrecurring fair value measurements

    Fair Value     Level 1     Level 2     Level 3  
Assets:                        
Long-lived assets held-for-sale   $ 70,400     $ —     $ —     $ 70,400  
    $ 70,400     $ —     $ —     $ 70,400  
Liabilities:                                
Warrants   $ (304 )   $ —     $ —     $ (304 )
    $ (304 )   $ —     $ —     $ (304 )

 

                            Benefit Plan  
                            Percentage  
    Fair Value     Level 1     Level 2     Level 3     Allocation  
Assets:                              
Derivative financial instruments   $ 2,438     $ 2,438     $ —     $ —          
Long-lived assets held-for-sale     70,400       —       —       70,400          
Defined benefit plan assets(1) (pooled separate accounts):                                        
Large U.S. Equity(2)     4,654       —       4,654       —       30 %
Small/Mid U.S. Equity(3)     2,348       —       2,348       —       15 %
International Equity(4)     2,596       —       2,596       —       17 %
Fixed Income(5)     6,056       —       6,056       —       38 %
    $ 88,492     $ 2,438     $ 15,654     $ 70,400          
Liabilities:                                        
Derivative financial instruments   $ (1,860 )   $ (1,860 )   $ —     $ —          
Warrants     (977 )     —       —       (977 )        
    $ (2,837 )   $ (1,860 )   $ —     $ (977 )        

 

 

(1) Included in derivative instruments in the consolidated balance sheets.

(2) This category includes investments in funds comprised of equity securities of large U.S. companies. The funds are valued using the net asset value method in which an average of the market prices for the underlying investments is used to value the fund.

(3) This category includes investments in funds comprised of equity securities of small- and medium-sized U.S. companies. The funds are valued using the net asset value method in which an average of the market prices for the underlying investments is used to value the fund.

(4) This category includes investments in funds comprised of equity securities of foreign companies including emerging markets. The funds are valued using the net asset value method in which an average of the market prices for the underlying investments is used to value the fund.

(5) This category includes investments in funds comprised of U.S. and foreign investment-grade fixed income securities, high-yield fixed income securities that are rated below investment-grade, U.S. treasury securities, mortgage-backed securities, and other asset-backed securities. The funds are valued using the net asset value method in which an average of the market prices for the underlying investments is used to value the fund.